Ratner, Paul
Andrews, Charles P.
Hampel, Frank C.
Martin, Bruce
Mohar, Dale E.
Bourrelly, Denis
Danaietash, Parisa
Mangialaio, Sara
Dingemanse, Jasper
Hmissi, Abdel
van Bavel, Jay
Clinical trials referenced in this document:
Documents that mention this clinical trial
Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies
https://doi.org/10.1186/s13223-017-0183-z
Documents that mention this clinical trial
Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies
https://doi.org/10.1186/s13223-017-0183-z
Funding for this research was provided by:
Actelion Pharmaceuticals
Article History
Received: 16 October 2016
Accepted: 6 February 2017
First Online: 4 April 2017